Experienced Pricing & Market Access professional with a proven track record of implementing global payer strategies to support optimal price and access for New Chemical Entities and life-cycle indications for new medications, including biologics and orphan drugs, in a wide range of diseases in respiratory, dermatology, gastroenterology and rheumatology.
Hands-on experience of giving strategic and science-based input into reimbursement and patient access and, clinical operations in all stages of pharmaceutical development from early stage to late-stage clinical development and, business development.
20+ years in the biopharmaceutical industry, working for international pharmaceutical companies and consulting organisations.